Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Neoplasms 2Sarcoma, Kaposi 1Neurofibromatosis 2 1Neurofibromatoses 1Neoplasms by Histologic Type 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid 1HIV Infections 1AIDS-related Kaposi sarcoma 1

Interventions

Gene Expression Profiling 2Biopsy 2ibrutinib 1fludarabine phosphate 1fludarabine 1emvododstat 1efineptakin alfa 1Zidovudine 1Whole-Body Irradiation 1Vorinostat 1Thiotepa 1Therapeutics 1Taxes 1Specimen Handling 1Rituximab 1Polymerase Chain Reaction 1Paclitaxel 1Nivolumab 1Methotrexate 1Magnetic Resonance Spectroscopy 1Leucovorin 1Ipilimumab 1Immunohistochemistry 1Genes 1Flow Cytometry 1Erlotinib Hydrochloride 1Dexamethasone 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × HIV Infections × emvododstat × Clear all
NCT00686842 2018-06-06

PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma

AIDS Malignancy Consortium

Phase 1/2 Terminated
17 enrolled 7 charts
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡